Genedrive Share Discussion Threads

[hazl] 02/2/2021 14:39

Calculus have an impressive number of shares


7.39 7.39 63,192,485

but sold just over 1% on the 16th December!

We are notified today. they must be annoyed they could have got another 50%+ if they had waited!

And more possibly by middle of February.
H
IMO

[richardp19] 02/2/2021 14:38

Tried to top up best I got was 87p

[billthebank] 02/2/2021 14:32

Richard is right No shares sold by calculus.Just dilution as BGF converted their loan note in December so lets get this show back on the road to £1.

[bunz3] 02/2/2021 14:32

5000 share buyer still able to get shares

[hooded claw] 02/2/2021 14:31

Nice little game being played as the RNS looked like an ii was selling when really it was down to the conversion of the remaining debt on the 11th December that dropped their %

[bunz3] 02/2/2021 14:26

N T to buy still ,so annoying

[hooded claw] 02/2/2021 14:24

There was talk that you would need a vaccine to travel but I think that is BS.

The vaccine does not stop you catching or spreading Covid it just stops the symptoms so you could be vaccinated but still have, and can spread Covid.

So you will need a negative test to prove you can travel and whether you are vaccinated or not is meaningless.

[richardp19] 02/2/2021 14:22

Guys they didn't sell dilution that's all

[hazl] 02/2/2021 14:19

A lot of entities got it wrong it seems to me.

They believed we would be up and running last year at some point!

Now we can anticipate the scenario....everybody having to have tests in the work place.
Nobody allowed to go on their Saga trips without the proof that they are trouble free.
Anywhere you go.
The big pharmas are going to be rolling in it.



But GDR has much more to offer!

IMO

[hooded claw] 02/2/2021 14:16

Over one and a half months to issue the RNS ? No wonder GDR RNS'ed the count the other day

[bunz3] 02/2/2021 14:15

cant buy with H L, NT to buy

[hazl] 02/2/2021 14:14

Richard I bet they are regretting it now!

[hazl] 02/2/2021 14:14

This in the sector....Genes....in future lists for trends going forward.
It's certainly had a head start!

[bunz3] 02/2/2021 14:11

cant buy nt to buy ,was going to top up

[richardp19] 02/2/2021 14:07

Sorry calculus dumped in December but notifying now

[richardp19] 02/2/2021 14:06

Now we have calculus shedding a few

[bunz3] 02/2/2021 14:00

with last weeks rns



be hoping £1 soon past


and hoping then £2 soon past


how many will want to be holding mid February


like this part of rns




The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing.



David Budd, CEO of genedrive plc, said: "We are very pleased to have the partnership of Beckman Coulter in accessing significant COVID testing opportunities throughout the United States and Europe, where the incidence of COVID continues to escalate and the need for high throughout testing solutions remains a priority. The combination of genedrive and Beckman Coulter products and expertise provides the Company with a new, innovative, and competitive solution, and a new sales channel for the American market, which we did not have previously.



"We are very pleased to now take our initial collaboration and development agreement to the commercial stage. Beckman Coulter is an important and significant company in these core geographies, well suited to promoting, selling, and supporting our products."



The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations.

[hooded claw] 02/2/2021 13:59

Seball, you can take the top one off now ;)

[seball] 02/2/2021 13:55

Upcoming news flow for: #GDR

Beckman validation
Beckman partnership & orders
Euro sales news
Full FDA approval
WHO approval
India Approval
Divoc deal
PoC device launch and CE mark
U.K. tender
US DoD contract to be signed
Launch of hearing loss kit
Hep C kit

Strong Buy this will rerate over next few months

[hazl] 02/2/2021 13:51

Lunch time is often a good time to buy I have found as the price often softens in any share.
Not only have we recent news...last week of the arrangement with Beckham Coulter...
an impressive firm from what I understand.... but it is right in the right sector currently.
Also we have the news to anticipate in mid-February.
What I am looking forward to are B and C's comments on this tie up.

[bunz3] 02/2/2021 13:49

5000 share buyer loading up with more tranches of shares

[bunz3] 02/2/2021 13:48

buy quote moving up some more again

[andymunchkin] 02/2/2021 13:47

WhyThe bidSells??? Leak???